Skip to content
Spencer Z. Rosero, M.D.

Spencer Z. Rosero, M.D.

Cardiology

UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

Locations

Cardiac Care

191 North Main Street
Wellsville, NY 14895

Electrophysiology Lab

601 Elmwood Avenue, Ground Floor, G-1200
Rochester, NY 14620

About Me

Dr. Rosero is a heart rhythm specialist providing care for patients with cardiac arrhythmias including atrial fibrillation, and ventricular tachycardia. He performs ablation of complex arrhythmias including atrial fibrillation and high-risk ventricular tachycardia. Dr. Rosero is an expert in complet...
Dr. Rosero is a heart rhythm specialist providing care for patients with cardiac arrhythmias including atrial fibrillation, and ventricular tachycardia. He performs ablation of complex arrhythmias including atrial fibrillation and high-risk ventricular tachycardia. Dr. Rosero is an expert in complete management of pacemakers, defibrillators, and resynchronization devices. He is board certified in Internal Medicine, Cardiovascular Disease and Clinical Cardiac Electrophysiology.

Professional Background

Dr. Spencer Z. Rosero is Professor of Medicine at the University of Rochester School of Medicine and Dentistry. He currently serves as Interim Chief of Cardiology . Until recently, he served as the Director of the Clinical Research Center at the Clinical and Translational Sciences Institute (CTSI). ...
Dr. Spencer Z. Rosero is Professor of Medicine at the University of Rochester School of Medicine and Dentistry. He currently serves as Interim Chief of Cardiology . Until recently, he served as the Director of the Clinical Research Center at the Clinical and Translational Sciences Institute (CTSI). and previously served as Clinical Director of the Center for Medical Technology and Innovation at the University of Rochester, an M.S. degree program in Biomedical Engineering through the Department of Biomedical Engineering providing students with specialized training in medical device design. He obtained his medical degree at the State University of New York Health Sciences Center Brooklyn and holds an M.S. degree in Pharmacology from the University of Rochester. Dr. Rosero completed his internal medicine, cardiology and electrophysiology fellowship training including the completion of the ABIM Clinical Investigator Pathway.

Dr. Rosero's research interests focuses on better understanding hereditary arrhythmias such as Long QT syndrome and on futuristic technologies, specifically multi-modal implantable and wearable sensors, that further the personalization of medicine. Dr. Rosero's interests include the translation of medical device-machine acquired data into clinically relevant biomarkers, with a focus on precision medicine. He has several issued and pending patents in his field and is currently developing an implantable biosensor that uses living cells embedded within the chip to provide real-time in-vivo monitoring of biological processes.

Languages

English, Spanish

Certified Specialties

Clinical Cardiac Electrophysiology - American Board of Internal Medicine

Faculty Appointments

Professor - Department of Medicine, Cardiology (SMD)

Credentials

Residency & Fellowship

Fellowship, Cardiovascular Disease, University of Rochester Medical Center. 1995 - 2000

Residency, Internal Medicine, University of Rochester Medical Center. 1994 - 1996

Internship, Internal Medicine, University of Rochester Medical Center. 1993 - 1994

Awards

Patient and Family Centered Care Top Performer Award. 2013

Heath Care Achievement Award for Innovation. 2012

Research

Patents

System and Method for Stimulation of Biologic Signals in a Bio-Electro-Physiologic Matrix

Issue date: September 20, 2011

Patent #: 8,024,020

Country: United States

Inventors: Spencer Z Rosero

Leadless Implantable Intravascular Electrophysiological Device for Neurologic/Cardiovascular Sensing and Stimulation

Issue date: January 20, 2015

Patent #: 8,938,300

Country: United States

Inventors: Spencer Z Rosero

Implantable Bio-Electro-Physiologic Interface Matrix

Issue date: September 30, 2014

Patent #: 8,849,416

Country: United States

Inventors: Spencer Z Rosero

Publications

Journal Articles

Utility of Cardiovascular Implantable Electronic Device-Derived Patient Activity to Predict Clinical Outcomes.

Rosero SZ, Younis A, Jones P, McNitt S, Goldenberg I, Zareba W, Stein K, Kutyifa V

Heart rhythm.. 2021 April 19 Epub 04/19/2021.

Outcome by Sex in Patients With Long QT Syndrome With an Implantable Cardioverter Defibrillator.

Younis A, Aktas MK, Rosero S, Kutyifa V, Polonsky B, McNitt S, Sotoodehnia N, Kudenchuk P, Rea TD, Arking DE, Goldenberg I, Zareba W

Journal of the American Heart Association.. 2020 October 209 (19):e016398. Epub 09/21/2020.

Mexiletine in myotonic dystrophy type-1: A randomized, double-blind, placebo-controlled trial.

Heatwole C, Luebbe E, Rosero S, Eichinger K, Martens W, Hilbert J, Dekdebrun J, Dilek N, Zizzi C, Johnson N, Puwanant A, Tawil R, Schifitto G, Beck CA, Richeson JF, Zareba W, Thornton C, McDermott MP, Moxley R

Neurology.. 2020 October 12 Epub 10/12/2020.

Utility of 6-Minute Walk Test to Predict Response to Cardiac Resynchronization Therapy in Patients With Mild Heart Failure.

Rosero SZ, Hernandez N, Goldenberg I, McNitt S, Plonsky B, Zareba W, Buber Y, Solomon SD, Kutyifa V

The American journal of cardiology.. 2020 July 14 Epub 07/14/2020.

Cardiac Resynchronization Therapy and Risk of Recurrent Hospitalizations in Patients Without Left Bundle Branch Block: The Long-Term Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy.

Vidula H, Lee E, McNitt S, Polonsky B, Aktas M, Rosero S, Younis A, Solomon SD, Zareba W, Kutyifa V, Goldenberg I

Circulation. Heart failure.. 2020 July 1 :CIRCHEARTFAILURE120006925. Epub 07/01/2020.

Deep Phenotyping of Parkinson's Disease.

Dorsey ER, Omberg L, Waddell E, Adams JL, Adams R, Ali MR, Amodeo K, Arky A, Augustine EF, Dinesh K, Hoque ME, Glidden AM, Jensen-Roberts S, Kabelac Z, Katabi D, Kieburtz K, Kinel DR, Little MA, Lizarraga KJ, Myers T, Riggare S, Rosero SZ, Saria S, Schifitto G, Schneider RB, Sharma G, Shoulson I, Stevenson EA, Tarolli CG, Luo J, McDermott MP

Journal of Parkinson's disease.. 2020 May 22 Epub 05/22/2020.

Need for pacing in patients who qualify for an implantable cardioverter-defibrillator: Clinical implications for the subcutaneous ICD.

Kutyifa V, Rosero SZ, McNitt S, Polonsky B, Brown MW, Zareba W, Goldenberg I

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.. 2020 January 29 :e12744. Epub 01/29/2020.

Relation between resting heart rate and the risk of ventricular tachyarrhythmias in MADIT-RIT.

Beinart R, Kutyifa V, McNitt S, Huang D, Aktas M, Rosero S, Goldenberg I, Nof E

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.. 2020 January 13 Epub 01/13/2020.

Prognostic Usefulness of Systolic Blood Pressure One-Year Following Cardiac Resynchronization Therapy (from MADIT-CRT).

Abdulla KH, Sherazi S, Goldenberg I, Kutyifa V, Zareba W, Huang DT, Rosero SZ, Polonsky B, McNitt S, Aktas MK

The American journal of cardiology.. 2019 December 9 Epub 12/09/2019.

Predictors and Outcomes of Atrial Tachyarrhythmia among Patients with Implantable Defibrillators.

Younis A, Heist EK, McNitt S, Aktas MK, Rosero S, Goldenberg I, Kutyifa V

Heart rhythm.. 2019 November 22 Epub 11/22/2019.

Quality of life predicting long-term outcomes in cardiac resynchronization therapy patients.

Nagy KV, Merkely B, Rosero S, Geller L, Kosztin A, McNitt S, Polonsky B, Goldenberg I, Zareba W, Kutyifa V

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.. 2019 October 16 Epub 10/16/2019.

Quantitative T-wave morphology assessment from surface ECG is linked with cardiac events risk in genotype-positive KCNH2 mutation carriers with normal QTc values.

Cortez D, Zareba W, McNitt S, Polonsky B, Rosero SZ, Platonov PG

Journal of cardiovascular electrophysiology.. 2019 October 3 Epub 10/03/2019.

Atrial Fibrillation in Long QT Syndrome by Genotype.

Platonov PG, McNitt S, Polonsky B, Rosero SZ, Zareba W

Circulation. Arrhythmia and electrophysiology.. 2019 October 12 (10):e007213. Epub 10/15/2019.

Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial.

Zareba W, Daubert JP, Beck CA, Huang DT, Alexis JD, Brown MW, Pyykkonen K, McNitt S, Oakes D, Feng C, Aktas MK, Ayala-Parades F, Baranchuk A, Dubuc M, Haigney M, Mazur A, McPherson CA, Mitchell LB, Natale A, Piccini JP, Raitt M, Rashtian MY, Schuger C, Winters S, Worley SJ, Ziv O, Moss AJ,

Journal of the American College of Cardiology.. 2018 August 772 (6):636-645. Epub 1900 01 01.

Risk Stratification of Type 2 Long-QT Syndrome Mutation Carriers With Normal QTc Interval: The Value of Sex, T-Wave Morphology, and Mutation Type.

Platonov PG, McNitt S, Polonsky B, Rosero SZ, Kutyifa V, Huang A, Moss AJ, Zareba W

Circulation. Arrhythmia and electrophysiology.. 2018 July 11 (7):e005918. Epub 1900 01 01.

Long-Term Survival With Implantable Cardioverter-Defibrillator in Different Symptomatic Functional Classes of Heart Failure.

Biton Y, Rosero S, Moss A, Zareba W, Kutyifa V, Baman J, Barsheshet A, McNitt S, Polonsky B, Goldenberg I

The American journal of cardiology.. 2018 March 1121 (5):615-620. Epub 12/11/2017.

Changes in paced signals may predict in-hospital cardiac arrest.

Attin M, Rosero SZ, Ding J, Nolan S, Tucker R

Pacing and clinical electrophysiology : PACE.. 2018 January 41 (1):2-6. Epub 12/08/2017.

The QT Scale: A Weight Scale Measuring the QTc Interval.

Couderc JP, Beshaw C, Niu X, Serrano-Finetti E, Casas O, Pallas-Areny R, Rosero S, Zareba W

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.. 2017 January 22 (1)Epub 07/15/2016.

Relationship between age and inappropriate implantable cardioverter-defibrillator therapy in MADIT-RIT (Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy).

Biton Y, Huang DT, Goldenberg I, Rosero S, Moss AJ, Kutyifa V, McNitt S, Strasberg B, Zareba W, Barsheshet A

Heart rhythm.. 2016 April 13 (4):888-93. Epub 12/19/2015.

The HARMONY Trial: Combined Ranolazine and Dronedarone in the Management of Paroxysmal Atrial Fibrillation: Mechanistic and Therapeutic Synergism.

Reiffel JA, Camm AJ, Belardinelli L, Zeng D, Karwatowska-Prokopczuk E, Olmsted A, Zareba W, Rosero S, Kowey P

Circulation. Arrhythmia and electrophysiology.. 2015 October 8 (5):1048-56. Epub 07/30/2015.

Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.

Kutyifa V, Bloch Thomsen PE, Huang DT, Rosero S, Tompkins C, Jons C, McNitt S, Polonsky B, Shah A, Merkely B, Solomon SD, Moss AJ, Zareba W, Klein H

Heart rhythm.. 2013 December 10 (12):1770-7. Epub 08/22/2013.

Ventricular fibrillation complicating endomyocardial biopsy of transplanted heart

Rozmus, G.; Patel, H.; Rosero, S.; Alexis, J. D.;.

2013; 18: 413-4.

Ambulatory ECG monitoring in atrial fibrillation management

Rosero, S. Z.; Kutyifa, V.; Olshansky, B.; Zareba, W.;.

2013; 56: 143-52.

Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D

Kutyifa, V.; Bloch Thomsen, P. E.; Huang, D. T.; Rosero, S.; Tompkins, C.; Jons, C.; McNitt, S.; Polonsky, B.; Shah, A.; Merkely, B.; Solomon, S. D.; Moss, A. J.; Zareba, W.; Klein, H. U.;.

2013; 10: 1770-7.

Ambulatory ECG monitoring in atrial fibrillation management.

Rosero SZ, Kutyifa V, Olshansky B, Zareba W

Progress in cardiovascular diseases.. 2013 56 (2):143-52. Epub 10/05/2013.

Reduction in inappropriate therapy and mortality through ICD programming.

Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NA, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W,

The New England journal of medicine.. 2012 December 13367 (24):2275-83. Epub 11/06/2012.

Syncope and exercise-related ventricular tachycardia.

Gallagher J, Huang DT, Wilde AA, Rosero SZ

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.. 2012 April 17 (2):146-50. Epub 1900 01 01.

Syncope and exercise-related ventricular tachycardia

Gallagher, J.; Huang, D. T.; Wilde, A. A.; Rosero, S. Z.;.

2012; 17: 146-50.

Direct left atrial pressure monitoring in severe heart failure: long-term sensor performance.

Troughton RW, Ritzema J, Eigler NL, Melton IC, Krum H, Adamson PB, Kar S, Shah PK, Whiting JS, Heywood JT, Rosero S, Singh JP, Saxon L, Matthews R, Crozier IG, Abraham WT,

Journal of cardiovascular translational research.. 2011 February 4 (1):3-13. Epub 10/14/2010.

Direct left atrial pressure monitoring in severe heart failure: long-term sensor performance

Troughton, R. W.; Ritzema, J.; Eigler, N. L.; Melton, I. C.; Krum, H.; Adamson, P. B.; Kar, S.; Shah, P. K.; Whiting, J. S.; Heywood, J. T.; Rosero, S.; Singh, J. P.; Saxon, L.; Matthews, R.; Crozier, I. G.; Abraham, W. T.; Investigators, Homeostasis;.

2011; 4: 3-13.

Time-dependent risk of Fidelis lead failure

Faulknier, B. A.; Traub, D. M.; Aktas, M. K.; Aguila, A.; Rosero, S.; Daubert, J. P.; Hall, B.; Shah, A.; Taylor, S.; McNitt, S.; Moss, A. J.; Zareba, W.; Huang, D. T.;.

2010; 105: 95-9.

Right ventricular dysfunction and the incidence of implantable cardioverter-defibrillator therapies.

Aktas MK, Kim DD, McNitt S, Huang DT, Rosero SZ, Hall BW, Zareba W, Daubert JP

Pacing and clinical electrophysiology : PACE.. 2009 December 32 (12):1501-8. Epub 09/30/2009.

Impact of atrial prevention pacing on atrial fibrillation burden: primary results of the Study of Atrial Fibrillation Reduction (SAFARI) trial.

Gold MR, Adler S, Fauchier L, Haffajee C, Ip J, Kainz W, Kawasaki R, Prakash A, Táborský M, Waller T, Wilson V, Li S, Hoffmann E,

Heart rhythm.. 2009 March 6 (3):295-301. Epub 12/06/2008.

Right ventricular dysfunction and the incidence of implantable cardioverter-defibrillator therapies

Aktas, M. K.; Kim, D. D.; McNitt, S.; Huang, D. T.; Rosero, S. Z.; Hall, B. W.; Zareba, W.; Daubert, J. P.;.

2009; 32: 1501-8.

Effect of biventricular pacing during a ventricular sensed event

Aktas, M. K.; Jeevanantham, V.; Sherazi, S.; Flynn, D.; Hall, B.; Huang, D. T.; Rosero, S.; Daubert, J. P.; Shah, A. H.;.

2009; 103: 1741-5.

Implantable electrocardiographic monitoring devices.

Rosero SZ

Cardiology journal.. 2009 16 (1):86-7. Epub 1900 01 01.

Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome.

Moss AJ, Zareba W, Schwarz KQ, Rosero S, McNitt S, Robinson JL

Journal of cardiovascular electrophysiology.. 2008 December 19 (12):1289-93. Epub 07/25/2008.

Congenital long QT syndrome: considerations for primary care physicians.

Levine E, Rosero SZ, Budzikowski AS, Moss AJ, Zareba W, Daubert JP

Cleveland Clinic journal of medicine.. 2008 August 75 (8):591-600. Epub 1900 01 01.

Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.

Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ,

Journal of the American College of Cardiology.. 2008 April 851 (14):1357-65. Epub 1900 01 01.

Ranolazine Shortens Repolarization and Improves Myocardial Relaxation in Patients with Type-3 Long QT Syndrome.

Moss, AJ; Zareba, W; Schwarz, KQ; Rosero, SZ; McNitt, S; Robinson, JL.

2008; .

Long QT syndrome: Current Status.

Levine, E; Rosero, SZ; Daubert, JP.

Cleveland Clinic J Med. 2008; .

Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome

Moss, A. J.; Zareba, W.; Schwarz, K. Q.; Rosero, S.; McNitt, S.; Robinson, J. L.;.

2008; 19: 1289-93.

Congenital long QT syndrome: considerations for primary care physicians

Levine, E.; Rosero, S. Z.; Budzikowski, A. S.; Moss, A. J.; Zareba, W.; Daubert, J. P.;.

2008; 75: 591-600.

Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact

Daubert, J. P.; Zareba, W.; Cannom, D. S.; McNitt, S.; Rosero, S. Z.; Wang, P.; Schuger, C.; Steinberg, J. S.; Higgins, S. L.; Wilber, D. J.; Klein, H.; Andrews, M. L.; Hall, W. J.; Moss, A. J.; Investigators, Madit Ii;.

2008; 51: 1357-65.

Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome.

Daubert JP, Zareba W, Rosero SZ, Budzikowski A, Robinson JL, Moss AJ

American heart journal.. 2007 April 153 (4 Suppl):53-8. Epub 1900 01 01.

Variation in left atrial wall thickness at sites commonly targeted for AF ablation.

Hall BW, Daubert JP, Rochelle S, Jeevanantham V, Vorobiof Gabriel, Filippone J, Zareba W, Moss A, Huang, DT, Rosero S, Shah A, Taylor S, Taubman M.

Journal of Interventional Electrophysiology. 2007; In Press.

Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome

Daubert JP, Zareba W, Rosero SZ, Budzikowski A, Robinson JL, Moss AJ.

Am Heart J. 2007; 153: s53-8.

Visualization of the esophagus during catheter ablation of atrial fibrillation.

Hall B, Shah A, Huang D, Rosero S, Daubert J

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing.. 2005 July 13 (2):135-7. Epub 1900 01 01.

Venous thrombosis and stenosis after implantation of pacemakers and defibrillators

Rozmus, G.; Daubert, J. P.; Huang, D. T.; Rosero, S.; Hall, B.; Francis, C.;.

2005; 13: 9-19.

Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial

Moss, A. J.; Windle, J. R.; Hall, W. J.; Zareba, W.; Robinson, J. L.; McNitt, S.; Severski, P.; Rosero, S.; Daubert, J. P.; Qi, M.; Cieciorka, M.; Manalan, A. S.;.

2005; 10: 59-66.

Visualization of the esophagus during catheter ablation of atrial fibrillation

Hall, B.; Shah, A.; Huang, D.; Rosero, S.; Daubert, J.;.

2005; 13: 135-7.

Update on implantable cardioverter defibrillator trials.

Shah AH, Huang DT, Rosero SZ, Daubert JP

Current cardiology reports.. 2004 September 6 (5):327-32. Epub 1900 01 01.

Novel compound heterozygous mutations in the KCNQ1 gene associated with autosomal recessive long QT syndrome (Jervell and Lange-Nielsen syndrome).

Ning L, Moss AJ, Zareba W, Robinson J, Rosero S, Ryan D, Qi M

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.. 2003 July 8 (3):246-50. Epub 1900 01 01.

Denaturing high-performance liquid chromatography quickly and reliably detects cardiac ion channel mutations in long QT syndrome

Ning, L.; Moss, A.; Zareba, W.; Robinson, J.; Rosero, S.; Ryan, D.; Qi, M.;.

2003; 7: 249-53.

Denaturing high-performance liquid chromatography quickly and reliably detects cardiac ion channel mutations in long QT syndrome.

Ning L, Moss A, Zareba W, Robinson J, Rosero S, Ryan D, Qi M

Genetic testing.. 2003 7 (3):249-53. Epub 1900 01 01.

Altered atrial, atrioventricular, and ventricular conduction in patients with the long QT syndrome caused by the DeltaKPQ SCN5A sodium channel gene mutation.

Zareba W, Sattari MN, Rosero S, Couderc JP, Moss AJ

The American journal of cardiology.. 2001 December 188 (11):1311-4. Epub 1900 01 01.

Effects of flecainide in patients with new SCN5A mutation: mutation-specific therapy for long-QT syndrome?

Benhorin J, Taub R, Goldmit M, Kerem B, Kass RS, Windman I, Medina A

Circulation.. 2000 April 11101 (14):1698-706. Epub 1900 01 01.

Newer indications for permanent pacemakers

Rosero, S. Z.; Akiyama, T.;.

2000; 26: 96-102.

Asthma and the risk of cardiac events in the Long QT syndrome. Long QT Syndrome Investigative Group.

Rosero SZ, Zareba W, Moss AJ, Robinson JL, Hajj Ali RH, Locati EH, Benhorin J, Andrews ML

The American journal of cardiology.. 1999 December 1584 (12):1406-11. Epub 1900 01 01.

Asthma and the risk of cardiac events in the Long QT syndrome. Long QT Syndrome Investigative Group

Rosero, S. Z.; Zareba, W.; Moss, A. J.; Robinson, J. L.; Hajj Ali, R. H.; Locati, E. H.; Benhorin, J.; Andrews, M. L.;.

1999; 84: 1406-11.

Electrocardiographic findings in patients with diphenhydramine overdose.

Zareba W, Moss AJ, Rosero SZ, Hajj-Ali R, Konecki J, Andrews M

The American journal of cardiology.. 1997 November 180 (9):1168-73. Epub 1900 01 01.

Electrocardiographic findings in patients with diphenhydramine overdose

Zareba, W.; Moss, A. J.; Rosero, S. Z.; Hajj-Ali, R.; Konecki, J.; Andrews, M.;.

1997; 80: 1168-73.

Lidocaine block of LQT-3 mutant human Na+ channels.

An RH, Bangalore R, Rosero SZ, Kass RS

Circulation research.. 1996 July 79 (1):103-8. Epub 1900 01 01.

Books

2001 Conns Current Therapy (2001)

Chapter: Tachycardias

Authors: Daubert JP, Rosero SZ, Corsello A.

Publisher: W.B. Saunders, Philadelphia, PA 2001

Ratings & Reviews

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.